glp-1 data LegitScript's Reveals 1200% Increase in Violative and Problematic Advertisements for Medications GLP-1 Agonists Market Exclusive Research

Anti-inflammatory therapies are under investigation for the regulation of neuroinflammation after traumatic brain injury (Harrison et al., 2014)

0.8% decrease

D.Moreno-IndiasI.TinahonesF

published preliminary results from the single ascending dose (SAD) phase of an ongoing Phase 1 clinical trial for CT-996, an oral small molecule GLP-1 receptor agonist (RA) that is presently being assessed in a first-in-human clinical trial in individuals who are overweight or obese

Abdominal pain, particularly if severe, persistent, or radiating to the back, may indicate pancreatitisa rare but serious adverse effect requiring emergency evaluation